Across TCGA pan-cancer cohorts, MIR200A Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR200A data layer compared with 20 for mass-spec protein.

The strongest signal is observed in sarcoma (SARC), where higher MIR200A Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR200A expression acts as an unfavorable survival marker.

SARC are the cancer types where MIR200A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	DFS	Median	All	0.089	0.611	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR200A tumor-vs-normal RNA expression · all MIR200A data types